微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 0.86% | 1.18% | 3.61% | 83/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 0.83% | 53.7% | 130.29% | 71/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -2.74% | -191.95% | -12.3% | 106/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -2.44% | -182.71% | -387.06% | 118/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 0.85% | -37.5% | 57.41% | 89/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.54% | -39.33% | -81.88% | 88/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 2.98% | -3.25% | 1.02% | 82/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 2.95% | -8.95% | 116.91% | 79/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 1.36% | -8.72% | 52.81% | 84/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.89% | 8.54% | -71.1% | 80/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 3.08% | -60.21% | -4.94% | 85/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.24% | -47.23% | 117.45% | 86/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.49% | -66.52% | 81.71% | 96/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.82% | 2% | -89.41% | 92/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 7.74% | -22.75% | 26.06% | 76/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 6.14% | 2% | 37.98% | 79/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.45% | 5.95% | -55.59% | 74/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2021-12-31 | 10.02% | 0.1% | 138.57% | 83/141 | 18.45% | 九安医疗 | 142.71% | 行业排名> |
| 2021-06-30 | 4.2% | 28.44% | -58.04% | 88/141 | 11.59% | 热景生物 | 121.78% | 行业排名> |
| 2020-12-31 | 10.01% | -5.83% | 206.12% | 91/141 | 26.27% | 热景生物 | 99.69% | 行业排名> |
| 2020-06-30 | 3.27% | -49.54% | -69.24% | 85/141 | 15.17% | 热景生物 | 99.09% | 行业排名> |
| 2019-12-31 | 10.63% | 2% | 64.04% | 76/141 | 14.66% | 热景生物 | 57.63% | 行业排名> |
| 2019-06-30 | 6.48% | 2% | 2% | 30/141 | 6.76% | 中红医疗 | 168% | 行业排名> |